 After its shares fell nearly 7 in a public debut last week, Ortho Clinical Diagnostics Holdings PLC NASDAQ:OCDX is clawing its way back to a modicum of respectability. The Raritan, New Jersey-based company is now trading at about 18 after hitting the public market at an already reduced price of 17. 